EGFR and hypopharynx cancer: Unlocking genetic commonalities between hypopharyngeal cancer and EGFR‐mutated lung adenocarcinoma using bioinformatics analysis, we identified 10 key hub genes suggesting potential therapeutic molecules for both diseases.